|
1
|
Dunn JE: Cancer epidemiology in
populations of the United States-with emphasis on Hawaii and
California-and Japan. Cancer Res. 35:3240–3245. 1975.PubMed/NCBI
|
|
2
|
Shimizu H, Ross RK, Bernstein L, Yatani R,
Henderson BE and Mack TM: Cancers of the prostate and breast among
Japanese and white immigrants in Los Angeles County. Br J Cancer.
63:963–966. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park SY, Haiman CA, Cheng I, Park SL,
Wilkens LR, Kolonel LN, Le Marchand L and Henderson BE:
Racial/ethnic differences in lifestyle-related factors and prostate
cancer risk: The multiethnic cohort study. Cancer Causes Control.
26:1507–1515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bostwick DG, Burke HB, Djakiew D, Euling
S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters
DJ and Timms B: Human prostate cancer risk factors. Cancer. 101:(10
Suppl). S2371–S2490. 2004. View Article : Google Scholar
|
|
5
|
Calle EE, Rodriguez C, Walker-Thurmond K
and Thun MJ: Overweight, obesity, and mortality from cancer in a
prospectively studied cohort of U.S. adults. N Engl J Med.
348:1625–1638. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andersson SO, Wolk A, Bergström R, Adami
HO, Engholm G, Englund A and Nyrén O: Body size and prostate
cancer: A 20-year follow-up study among 135006 Swedish construction
workers. J Natl Cancer Inst. 89:385–389. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giovannucci E, Rimm EB, Liu Y, Leitzmann
M, Wu K, Stampfer MJ and Willett WC: Body mass index and risk of
prostate cancer in U.S. health professionals. J Natl Cancer Inst.
95:1240–1244. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Discacciati A, Orsini N and Wolk A: Body
mass index and incidence of localized and advanced prostate
cancer-a dose-response meta-analysis of prospective studies. Ann
Oncol. 23:1665–1671. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rodriguez C, Patel AV, Calle EE, Jacobs
EJ, Chao A and Thun MJ: Body mass index, height, and prostate
cancer mortality in two large cohorts of adult men in the United
States. Cancer Epidemiol Biomarkers Prev. 10:345–353.
2001.PubMed/NCBI
|
|
10
|
Freedland SJ, Bañez LL, Sun LL, Fitzsimons
NJ and Moul JW: Obese men have higher-grade and larger tumors: An
analysis of the duke prostate center database. Prostate Cancer
Prostatic Dis. 12:259–263. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chamie K, Oberfoell S, Kwan L, Labo J, Wei
JT and Litwin MS: Body mass index and prostate cancer severity: Do
obese men harbor more aggressive disease on prostate biopsy?
Urology. 81:949–955. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tomaszewski JJ, Chen YF, Bertolet M,
Ristau BT, Woldemichael E and Nelson JB: Obesity is not associated
with aggressive pathologic features or biochemical recurrence after
radical prostatectomy. Urology. 81:992–996. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Amling CL, Riffenburgh RH, Sun L, Moul JW,
Lance RS, Kusuda L, Sexton WJ, Soderdahl DW, Donahue TF, Foley JP,
et al: Pathologic variables and recurrence rates as related to
obesity and race in men with prostate cancer undergoing radical
prostatectomy. J Clin Oncol. 22:439–445. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Freedland SJ, Aronson WJ, Kane CJ, Presti
C Jr, Amling CL, Elashoff D and Terris MK: Impact of obesity on
biochemical control after radical prostatectomy for clinically
localized prostate cancer: A report by the Shared Equal Access
Regional Cancer Hospital database study group. J Clin Oncol.
22:446–453. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freedland SJ, Terris MK, Presti JC Jr,
Amling CL, Kane CJ, Trock B and Aronson WJ: Search Database Study
Group: Obesity and biochemical outcome following radical
prostatectomy for organ confined disease with negative surgical
margins. J Urol. 172:520–524. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Freedland SJ, Grubb KA, Yiu SK, Humphreys
EB, Nielsen ME, Mangold LA, Isaacs WB and Partin AW: Obesity and
risk of biochemical progression following radical prostatectomy at
a tertiary care referral center. J Urol. 174:919–922. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Freedland SJ, Isaacs WB, Mangold LA, Yiu
SK, Grubb KA, Partin AW, Epstein JI, Walsh PC and Platz EA:
Stronger association between obesity and biochemical progression
after radical prostatectomy among men treated in the last 10 years.
Clin Cancer Res. 11:2883–2888. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SE, Lee WK, Jeong MS, Abdullajanov M,
Kim DS, Park HZ, Jeong SJ, Yoon CY, Byun SS, Choe G and Hong SK: Is
body mass index associated with pathological outcomes after radical
prostatectomy in Korean men? BJU Int. 107:1250–1255. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai PD, Hu MB, Xu H, Zhu WH, Hu JM, Yang
T, Jiang HW and Ding Q: Body mass index is associated with higher
Gleason score and biochemical recurrence risk following radical
prostatectomy in Chinese men: A retrospective cohort study and meta
analysis. World J Surg Oncol. 13:3112015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Komaru A, Kamiya N, Suzuki H, Endo T,
Takano M, Yano M, Kawamura K, Imamoto T and Ichikawa T:
Implications of body mass index in Japanese patients with prostate
cancer who had undergone radical prostatectomy. Jpn J Clin Oncol.
40:353–359. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Narita S, Mitsuzuka K, Yoneyama T,
Tsuchiya N, Koie T, Kakoi N, Kawamura S, Kaiho Y, Ohyama C, Tochigi
T, et al: Impact of body mass index on clinicopathological outcome
and biochemical recurrence after radical prostatectomy. Prostate
Cancer Prostatic Dis. 16:271–276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Epstein JI, Egevad L, Amin MB, Delahunt B,
Srigley JR and Humphrey PA: Grading Committee: The 2014
international society of urological pathology (ISUP) consensus
conference on gleason grading of prostatic carcinoma: Definition of
grading patterns and proposal for a new grading system. Am J Surg
Pathol. 40:244–252. 2016.PubMed/NCBI
|
|
23
|
Baillargeon J, Pollock BH, Kristal AR,
Bradshaw P, Hernandez J, Basler J, Higgins B, Lynch S, Rozanski T,
Troyer D and Thompson I: The association of body mass index and
prostate-specific antigen in a population-based study. Cancer.
103:1092–1095. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Werny DM, Thompson T, Saraiya M, Freedman
D, Kottiri BJ, German RR and Wener M: Obesity is negatively
associated with prostate-specific antigen in U.S. men, 2001–2004.
Cancer Epidemiol Biomarkers Prev. 16:70–76. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bañez LL, Hamilton RJ, Partin AW, Vollmer
RT, Sun L, Rodriguez C, Wang Y, Terris MK, Aronson WJ, Presti JC
Jr, et al: Obesity-related plasma hemodilution and PSA
concentration among men with prostate cancer. JAMA. 298:2275–2280.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rundle A, Richards C and Neugut AI: Body
composition, abdominal fat distribution and prostate-specific
antigen test results. Cancer Epidemiol Biomarkers Prev. 18:331–336.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grubb RL III, Black A, Izmirlian G, Hickey
TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD,
et al: Serum prostate-specific antigen hemodilution among obese men
undergoing screening in the prostate, lung, colorectal, and ovarian
cancer screening trial. Cancer Epidemiol Biomarkers Prev.
18:748–751. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park SG, Choi HC, Cho B, Kwon YM, Kwon HT
and Park JH: Effect of central obesity on prostate specific antigen
measured by computerized tomography: Related markers and prostate
volume. J Urol. 187:1589–1593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buschemeyer WC III and Freedland SJ:
Obesity and prostate cancer: Epidemiology and clinical
implications. Eur Urol. 52:331–343. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arisan ED, Arisan S, Atis G, Palavan-Unsal
N and Ergenekon E: Serum adipocytokine levels in prostate cancer
patients. Urol Int. 82:203–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagamatsu H, Teishima J, Goto K, Shikuma
H, Kitano H, Shoji K, Inoue S and Matsubara A: FGF19 promotes
progression of prostate cancer. Prostate. 75:1092–1101. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salomon L, Levrel O, de la Taille A,
Anastasiadis AG, Saint F, Zaki S, Vordos D, Cicco A, Olsson LE,
Hoznek A, et al: Radical prostatectomy by the retropubic, perineal
and laparoscopic approach: 12 years of experience in one center.
Eur Urol. 42:104–111. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lim SK, Kim KH, Shin TY and Rha KH:
Current status of robot-assisted laparoscopic radical
prostatectomy: How does it compare with other surgical approaches?
Int J Urol. 20:271–284. 2013. View Article : Google Scholar : PubMed/NCBI
|
